The 20 Best Lhermitte-Duclos Disease Doctors Near Me in Washington, DC

Ramon Sanchez is a Pediatric Radiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 33 years. Dr. Sanchez is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hirschsprung Disease, Scoliosis, Caudal Regression Syndrome, and Spondylocarpotarsal Synostosis Syndrome. Dr. Sanchez is board certified in Pediatric Radiology: American Board Of Radiology, 2014 and Diagnostic Radiology: American Board Of Radiology, 2012.

Eglal Shalaby-Rana, MD, is a radiologist in the Division of Diagnostic Imaging and Radiology at Children's National Hospital. She is the director of performance improvement. Dr. Rana is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Hirschsprung Disease, Scoliosis, Knock Knees, and Biliary Atresia. Dr. Rana is board certified in Pediatric Radiology: American Board Of Radiology, 1995 and Diagnostic Radiology: American Board Of Radiology, 1987.

Sarah Wright, DO, completed her medical training at the New York College of Osteopathic Medicine and her residency training in child neurology at the Children's Hospital of Montefiore in Bronx, NY. She then completed additional subspecialty fellowship training in clinical neurophysiology (neuromuscular focus) at Boston Children's Hospital and Lahey Hospital & Medical Center in Boston, MA. Dr. Wright evaluates and cares for children and young adults with both hereditary and acquired nerve and muscle disorders, including spinal muscular atrophy, Duchenne muscular dystrophy, Charcot Marie Tooth hereditary neuropathy, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. Dr. Wright's research interests include pediatric myasthenia gravis and discovering novel therapeutic approaches for Duchenne muscular dystrophy. Publications ORCiD. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. Her clinical expertise encompasses Spinal Muscular Atrophy Type 1, Seizures, Dysferlinopathy, and Genetic Epilepsy with Febrile Seizures Plus (GEFS+). Dr. Wright is board certified in American Board Of Psychiatry And Neurology, 2023 and American Board Of Psychiatry And Neurology, 2021.

Patroula Smpokou is a Medical Genetics provider practicing medicine in Washington, Washington, D.c.. Dr. Smpokou is rated as an Advanced provider by MediFind in the treatment of Lhermitte-Duclos Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses RASopathies, Noonan Syndrome, Lhermitte-Duclos Disease, and Bannayan-Riley-Ruvalcaba Syndrome.

William D. Gaillard, MD, professor of neurology and neurophysiology, is chief of the Divisions of Child Neurology and of Epilepsy and Neurophysiology. He is director of the Comprehensive Pediatric Epilepsy Program — one of the leading multidisciplinary pediatric epilepsy programs in the country. As associate director of the Children’s National Research Institute’s Center for Neuroscience Research, he is responsible for overseeing and organizing clinical neuroscience research. Dr. Gaillard is professor of pediatrics and neurology at the George Washington University School of Medicine; Professor of Neurology, Georgetown University; and Adjunct Professor of Hearing and Speech Sciences, University of Maryland, College Park. Additionally, Dr. Gaillard holds longstanding collaborations with the Clinical Epilepsy Section (CES), National Institute of Neurological Disorders and Stroke and NIH. His innovative research utilizes advanced structural and functional imaging to examine the effects of epilepsy on brain structure and function. His pioneering work with functional imaging has changed clinical practice for patients with epilepsy, made important technical contributions to structural and functional imaging methods, and provided fundamental scientific insights on the biology of brain plasticity. Ultimately, the goal of his research is to improve the outcomes and lives of children with epilepsy. Dr. Gaillard is a past president of the American Epilepsy Society. He is past treasurer of the American Epilepsy Society, past chair of the International League Against Epilepsy (ILAE) Commission on Diagnostics, past chair of the ILAE Pediatric Epilepsy Surgery Task Force and past member of the Pediatric Commission. He is a past editor of Epilepsy Research and a past editor of Epilepsia. He is the author of more than 240 peer-reviewed scientific papers and more than 50 chapters and holds longstanding federal and foundation grant funding. Dr. Gaillard is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Status Epilepticus, Liver Embolization, and Deep Brain Stimulation. Dr. Gaillard is board certified in American Board Of Psychiatry And Neurology, Pediatrics: American Board Of Pediatrics, 2005, and American Board Of Psychiatry And Neurology, 1992.

Hasan R. Syed, MD, was born in Morganton, NC and raised outside of Washington, D.C. He graduated as valedictorian of his high school class and attended Virginia Commonwealth University (VCU) as a Presidential Scholar in the Honors College. While in Richmond, he majored in Biomedical Engineering and graduated summa cum laude. He remained at VCU to complete his medical degree, where he was elected to the Alpha Omega Alpha Honor Medical Society. During this time, Dr. Syed was awarded funding through the Office of Research for a master’s degree to investigate cancer stem cell biology at King's College London. Dr. Syed completed his internship and neurological surgery residency at Georgetown University under Kevin McGrail, MD He received numerous awards during his training, including the resident traveling fellowship from the AANS/CNS Section on pediatric neurosurgery, and published manuscripts, book chapters and delivered oral presentations on both adult and pediatric brain and spinal disorders. Following completion of his post-graduate training, he relocated to Chicago to complete a prestigious subspecialty fellowship in pediatric neurosurgery at Ann & Robert H. Lurie Children's Hospital, Northwestern University under renowned pediatric neurosurgeon Tad Tomita, MD After spending three years at the University of Virginia as an assistant professor and associate residency program director, Dr. Syed joined Children’s National Hospital as an associate professor and fellowship director with a focus in pediatric neurosurgery. His clinical interests include brain and spinal tumors, hydrocephalus, craniosynostosis, Chiari malformation, epilepsy, spinal dysraphism, spasticity, craniocervical spinal disorders, peripheral nerve injuries and Moyamoya disease. He also has a strong interest in minimal access surgeries for brain and spinal disorders in pediatric patients. Dr. Syed is certified by the American Board of Neurological Surgery (ABNS) and the American Board of Pediatric Neurosurgery (ABPNS). Outside of work, his interests include traveling and spending time with his family in Washington, D.C. Dr. Syed is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Metopic Ridge, Craniosynostosis, Spinal Fusion, and Laminectomy. Dr. Syed is board certified in American Board Of Neurological Surgery, 2020.

Marc DiSabella, DO, is an associate professor of Pediatrics and Neurology at Children’s National Hospital in Washington, D.C., which is consistently ranked one of the best pediatric neurology and neurosurgery programs in the country by U.S. News & World Report. Dr. DiSabella serves as director of the Headache Program and was promoted to associate chief of Neurology Operations in 2024. Previously, he served 13 years as the Child Neurology Residency Program director where he graduated nearly 50 child neurology residents who now serve as division chiefs, VPs and have amassed millions in grant funding. Dr. DiSabella obtained his master's degree in leadership and education at the George Washington School of Medicine and Health Sciences and enjoys teaching and engaging his students and colleagues in educational innovation and improved teaching sessions. He currently has 10 industry sponsored clinical trials on which he serves as primary investigator in addition to a busy clinical practice. Dr. Disabella is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses New Daily Persistent Headache (NDPH), Migraine, Migraine with Brainstem Aura, and Opisthotonos. Dr. Disabella is board certified in American Board Of Psychiatry And Neurology, 2008.

Kuntal Sen, MD, is the co-director of Neurogenetics Clinic in the Division of Neurogenetics and Neurodevelopmental Pediatrics at Children's National Hospital. He is a graduate of Grant Government Medical College, Mumbai. He completed a combined pediatrics-medical genetics and genomics residency at the Detroit Medical Center/Wayne State University of Medicine. He then completed a child neurology fellowship at Children’s National. He also worked at the National Institutes of Health as a volunteer for the Undiagnosed Diseases Program. He is one of the few physicians in the country with dual training in neurology and clinical genetics which affords him a unique expertise to diagnose and manage patients with complex monogenic neurological disorders. Dr. Sen’s clinical expertise is centered on providing long-term, holistic, and family-centered care for patients with mitochondrial diseases and other ultra-rare neuro-metabolic disorders. Dr. Sen's research focus is on multi-modal neuroimaging and neuromonitoring in inborn errors of metabolism. Dr. Sen has published several peer-reviewed articles and presented at many international conferences on newborn screening disorders, rare neurometabolic epilepsies and ethics in genetic testing. Dr. Sen spearheaded a national survey aimed at identifying innovative approaches to educate child neurologists about genomic testing. This initiative culminated in the development and release of a national curriculum through the Child Neurology Society, under his leadership. He was elected chair of the Neurogenetics Section of the American Academy of Neurology, reflecting his national recognition in the field. He is a fellow of the American College of Medical Genetics (ACMG) and a member of the ACMG Advocacy and Government Affairs Committee. He also serves as the media editor for the Pediatric Neurology Journal. During his medical training, he has won awards and grants from professional societies including the prestigious ACMG Foundation/Perkin Elmer Award and Children’s National Founders Auxiliary Board Grant. Publications Google Scholar. Dr. Sen is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Hydranencephaly, Lissencephaly 2, and Cortical Dysplasia. Dr. Sen is board certified in American Board Of Psychiatry And Neurology, 2022 and Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2019.

Chima Oluigbo, MD, FRCSC, FAANS, is a pediatric neurosurgeon at Children’s National Hospital and Professor of Neurological Surgery, Neurology and Pediatrics at the George Washington University School of Medicine. He completed his residency in neurological surgery at University Hospitals Birmingham, England and subsequently completed fellowships at the University of Colorado (pediatric neurosurgery) and the Ohio State University (functional and stereotactic neurosurgery). He is board certified by the American Board of Pediatric Neurological Surgery and the Royal College of Physicians and Surgeons of Canada. He is a Fellow of the American Association of Neurological Surgeons (AANS) and an active member of the Congress of Neurological Surgeons (CNS) and the AANS/CNS Section on Pediatric Neurological Surgery. Dr. Oluigbo cares for children with all types of diseases of the nervous system such as epilepsy, brain and spine tumors, hydrocephalus, craniosynostosis, spina bifida and tethered spinal cord. He specializes in the surgical care of children with epilepsy as well as pediatric functional and restorative neurosurgery. He uses minimally invasive techniques to treat patients with epilepsy. These techniques include the Visualase laser ablation therapy and the ROSA robot assisted epilepsy surgery. He also uses advanced intraoperative magnetic resonance imaging (iMRI) during epilepsy surgery to optimize seizure control outcomes. Dr. Oluigbo previously led the epilepsy surgery service at the Ohio State University Medical Center where he was actively involved in functional neurosurgery (deep brain stimulation). His research interests include epilepsy surgery, deep brain stimulation, functional neurological restoration and the development of innovative neuromodulation therapies for the treatment of chronic neurological disorders including epilepsy, movement disorders, neurobehavioral and cognitive disorders, chronic pain and spasticity in children. Dr. Oluigbo is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Cortical Dysplasia, Epilepsy, Seizures, Posterior Fossa Decompression, and Craniectomy. Dr. Oluigbo is board certified in American Board Of Pediatric Neurological Surgery, 2014.

Seth Berger, MD, PhD, returned to Children’s National Hospital as faculty in 2018. He completed the medical scientist training program at Mount Sinai School of Medicine in New York where he was awarded his MD and PhD degrees. His research at that time focused on computational analysis of signaling networks applied to prediction of adverse drug events and cardiac arrhythmia syndromes. He subsequently completed the combined pediatrics and medical genetics residency program through Children's National and the National Human Genome Research Institute at the National Institutes of Health (NIH). He spent an additional year completing the medical biochemical genetics fellowship program at NIH before returning to Children's National where he was jointly hired by the Rare Disease Institute and the Center for Genetic Medicine Research. He is interested in developing novel bioinformatics approaches applied to variant discovery for rare diseases. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Alpha Thalassemia. Dr. Berger is board certified in Medical Biochemical Genetics: American Board Of Medical Genetics And Genomics, 2019, Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2017, and Pediatrics: American Board Of Pediatrics, 2016.

Daniel A. Donoho, MD, received an undergraduate degree from Dartmouth College (economics) and medical degree from SUNY- Stony Brook, where he was elected to the Alpha Omega Alpha Honor Medical Society. Dr. Donoho’s research included clinical and translational research in neuroendocrinology, including studies investigating growth hormone replacement and oxytocin function. Dr. Donoho completed his internship and neurological surgery residency at the University of Southern California where he learned from the mentorship of renowned surgeons including Steven L. Giannotta, MD, J. Gordon McComb MD and Martin Weiss, MD He has published over 50 manuscripts and book chapters and given many presentations and invited lectures on innovations in adult and pediatric brain and spinal disorders. During his residency, he completed a prestigious fellowship in endoscopic, minimally disruptive surgery for tumors and other conditions of the skull base under the tutelage of Edward R. Laws, Jr. MD at Harvard Medical School. Following completion of his post-graduate training, he completed a top-tier subspecialty fellowship in pediatric neurosurgery at Texas Children’s Hospital and he was a clinical instructor in the Baylor College of Medicine. Dr. Donoho is excited to join Children’s National Hospital and George Washington University as an assistant professor of pediatric neurosurgery. His clinical interests include brain tumors, pituitary tumors and craniopharyngiomas, rathke’s cleft cysts, spinal tumors, hydrocephalus, myelomeningocele, spina bifida, Chiari malformation, spinal malformations and trauma, spinal dysraphism and craniocervical spinal disorders. He is available for pediatric and prenatal consultations in person and via telehealth. Dr. Donoho’s research appointments are in the faculty of the George Washington University School of Medicine and Health Sciences, the Children’s National Center for Neuroscience Research and the Sheikh Zayed Institute for Pediatric Surgical Innovation. His research group studies surgical education and technological innovations that improve surgical safety. He founded one of the first neurosurgical computer vision research groups with mentors and collaborators at the University of Southern California and Caltech where he maintains an active collaboration. He is currently engaged in studies of surgeon performance using computer vision and machine learning. Dr. Donoho is eligible for certification by the American Board of Neurological Surgery (ABNS) and the American Board of Pediatric Neurosurgery (ABPNS). Publications Google Scholar. Dr. Donoho is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Metopic Ridge, Craniosynostosis, Sunken Fontanelles, Endoscopic Transnasal Transsphenoidal Surgery, and Laminectomy. Dr. Donoho is board certified in American Board Of Neurological Surgery, 2024.

John M. Schreiber, MD, FAES, is the Associate Chief of Epilepsy and EEG Operations, Medical Director of EEG and the Epilepsy Monitoring Unit and the director of Epilepsy Genetics at Children's National Hospital. After earning his medical degree cum laude at the University of Maryland School of Medicine, he completed Pediatrics and Child Neurology training at Children’s National Hospital. Before returning in 2013, he served as an Epilepsy and Clinical Neurophysiology Fellow at the National Institutes of Health, gaining experience in epilepsy clinical trials and in neurogenetic disorders. His primary clinical and research interests are on the diagnosis, evaluation and treatment of genetically-mediated epilepsies, particularly channelopathies. Dr. Schreiber is the principal investigator at Children’s National for various epilepsy observational and interventional clinical trials with a focus on neurogenetic disorders. He serves on the Pediatric Epilepsy Research Consortium board, is the co-chair for the Investigators' Workshop Committee of the American Epilepsy Society, and serves on the Epilepsy Foundation Professional Advisory Board and several other advisory boards. Publications PUBMED. Dr. Schreiber is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Myoclonic Epilepsy, Seizures, and Epilepsy with Myoclonic-Atonic Seizures. Dr. Schreiber is board certified in Epilepsy: American Board Of Psychiatry And Neurology, 2016, American Board Of Psychiatry And Neurology, 2013, and American Board Of Psychiatry And Neurology, 2011.

Wei-Liang Chen, MD, specialized in child neurology and genetics with focus on epilepsy, infantile spasm, brain malformation and other neurodevelopmental disorders. Dr. Chen is in charge of treatment trials in epilepsy. He is the site investigator in a national research consortium, Pediatric Epilepsy Research Consortium (PERC) Infantile Spasm group. He is also the principal investigator for the Epileptic Encephalopathy program at Children's National Hospital and serves as co-investigator in several other research projects focusing on neurogenetic diseases, neurometabolic disorders and functional neuroimaging. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Megalencephaly-Capillary Malformation Syndrome, Seizures, Epilepsy, and Landau-Kleffner Syndrome. Dr. Chen is board certified in American Board Of Medical Genetics And Genomics, 2021, Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2019, and Neurology With Special Qualification In Child Neurology: American Board Of Psychiatry And Neurology, 2018.

Alpa Vashist is a Neurologist practicing medicine in Washington, Washington, D.c.. Dr. Vashist is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Seizures, Epilepsy, and Generalized Tonic-Clonic Seizure. Dr. Vashist is currently accepting new patients.

Priyanka Kanth is a Gastroenterologist practicing medicine in Washington, Washington, D.c.. Dr. Kanth is rated as an Experienced provider by MediFind in the treatment of Lhermitte-Duclos Disease. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Familial Adenomatous Polyposis, Familial Colorectal Cancer, Colorectal Cancer, Endoscopy, and Colonoscopy.